-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS ANNOUNCES HEALTH CANADA APPROVAL OF IMCIVREE® (SETMELANOTIDE) FOR WEIGHT MANAGEMENT IN ADULT AND PEDIATRIC PATIENTS 4 YEARS OF AGE AND OLDER WITH ACQUIRED HYPOTHALAMIC OBESITY

路透·09/22/2026 12:00:04

登录查看新闻详情